Please enable JavaScript to continue using this application.

Compare $BEAM vs $IRON | Chartloom

Compare

$BEAM vs $IRON

Beam Therapeutics Inc · Disc Medicine Inc

BEAM

Beam Therapeutics Inc

IRON

Disc Medicine Inc

Compare $BEAM vs $IRON

Comparing Beam Therapeutics Inc and Disc Medicine Inc

BEAMBeam Therapeutics Inc

IRONDisc Medicine Inc

BEAMBeam Therapeutics Inc

Market cap

$2.64B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

38.86x

Rev growth (TTM)

158.9%

YTD performance

-5.3%

52W performance

-4.8%

FCF yield

-14.1%

IRONDisc Medicine Inc

Market cap

$2.37B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-21.5%

52W performance

-11.7%

FCF yield

-8.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BEAM

IRON

Detailed metrics comparison

BEAM

Beam Therapeutics Inc

IRON

Disc Medicine Inc

Market Cap

BEAM$2.64B

IRON$2.37B

Enterprise Value

BEAM$2.52B

IRON$2.33B

Price

BEAM$25.70

IRON$62.06

P/E Ratio

BEAMN/A

IRONN/A

P/S Ratio

BEAM16.95x

IRON0.00x

EV/Sales

BEAM16.18x

IRON0.00x

EV/EBITDA

BEAM0.00x

IRON0.00x

P/B Ratio

BEAM2.37x

IRON3.84x

P/FCF Ratio

BEAMN/A

IRONN/A

EV/FCF

BEAM-6.77x

IRON-11.80x

PEG Ratio

BEAMN/A

IRONN/A

Forward P/E (NTM)

BEAMN/A

IRONN/A

Forward P/S (NTM)

BEAM38.86x

IRONN/A

Revenue (TTM)

BEAM$156M

IRON$0

Revenue Growth (YoY)

BEAM158.9%

IRONN/A

Forward Rev Growth

BEAM17.9%

IRON300.5%

Gross Margin (TTM)

BEAM0.0%

IRON0.0%

Operating Margin (TTM)

BEAM0.0%

IRON0.0%

EBITDA Margin (TTM)

BEAM-228.0%

IRON0.0%

Net Margin (TTM)

BEAM-54.7%

IRON0.0%

FCF Margin (TTM)

BEAM-238.9%

IRONN/A

Net Income (TTM)

BEAM$-85M

IRON$-246M

FCF (TTM)

BEAM$-373M

IRON$-198M

EPS (TTM)

BEAM-$0.82

IRON-$6.36

ROE (TTM)

BEAM-770.0%

IRON-3717.0%

ROA (TTM)

BEAM-604.0%

IRON-3365.0%

ROIC (TTM)

BEAM-737.0%

IRON-3522.0%

Cash

BEAM$220M

IRON$99M

Debt

BEAM$100M

IRON$59M

Net Cash/Debt

BEAM$120M

IRON$39M

Current Ratio (TTM)

BEAM14.57x

IRON24.14x

Quick Ratio (TTM)

BEAM14.25x

IRON23.64x

Debt/Equity (TTM)

BEAM0.09x

IRON0.09x

Debt/Assets (TTM)

BEAM0.0%

IRON0.0%

Interest Coverage (TTM)

BEAMN/A

IRONN/A

Net Debt/EBITDA (TTM)

BEAM0.00x

IRON0.00x

Beta

BEAM2.26

IRON0.95

52W Performance

BEAM-4.8%

IRON-11.7%

YTD Performance

BEAM-5.3%

IRON-21.5%

% from 52W High

BEAM-32.8%

IRON-37.6%

% from 52W Low

BEAM27.0%

IRON55.2%

Asset Turnover (TTM)

BEAM0.11x

IRON0.00x

FCF Yield (TTM)

BEAM-14.1%

IRON-8.3%

Earnings Yield (TTM)

BEAM-3.2%

IRON-10.4%

Dividend Yield (TTM)

BEAMN/A

IRONN/A

Rule of 40

BEAM-80.0

IRON0.0

EV/GP/RG

BEAMN/A

IRONN/A

Ticker research

View BEAM research View IRON research

Metric	BEAM Beam Therapeutics Inc	IRON Disc Medicine Inc
Market & Valuation
Market Cap	$2.64B	$2.37B
Enterprise Value	$2.52B	$2.33B
Price	$25.70	$62.06
P/E Ratio	N/A	N/A
P/S Ratio	16.95x	0.00x
EV/Sales	16.18x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.37x	3.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.77x	-11.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	38.86x	N/A
Revenue & Growth
Revenue (TTM)	$156M	$0
Revenue Growth (YoY)	158.9%	N/A
Forward Rev Growth	17.9%	300.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-228.0%	0.0%
Net Margin (TTM)	-54.7%	0.0%
FCF Margin (TTM)	-238.9%	N/A
Net Income (TTM)	$-85M	$-246M
FCF (TTM)	$-373M	$-198M
EPS (TTM)	-$0.82	-$6.36
ROE (TTM)	-770.0%	-3717.0%
ROA (TTM)	-604.0%	-3365.0%
ROIC (TTM)	-737.0%	-3522.0%
Financial Health
Cash	$220M	$99M
Debt	$100M	$59M
Net Cash/Debt	$120M	$39M
Current Ratio (TTM)	14.57x	24.14x
Quick Ratio (TTM)	14.25x	23.64x
Debt/Equity (TTM)	0.09x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	0.95
52W Performance	-4.8%	-11.7%
YTD Performance	-5.3%	-21.5%
% from 52W High	-32.8%	-37.6%
% from 52W Low	27.0%	55.2%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-14.1%	-8.3%
Earnings Yield (TTM)	-3.2%	-10.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-80.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BEAM research	View IRON research

Valuation

P/S Ratio

IRON

0.00x

BEAM

16.95x

EV/FCF

IRON

-11.80x

BEAM

-6.77x

Growth & revenue

Revenue Growth TTM

BEAM

158.9%

Forward Revenue Growth

IRON

300.5%

BEAM

17.9%

Profitability & performance

Gross Margin

BEAM

0.0%

IRON

0.0%

ROE

BEAM

-770.0%

IRON

-3717.0%

FCF Yield %

IRON

-8.3%

BEAM

-14.1%

52-Week Performance

BEAM

-4.8%

IRON

-11.7%

Detailed metrics comparison

BEAM

Beam Therapeutics Inc

IRON

Disc Medicine Inc

Market Cap

BEAM$2.64B

IRON$2.37B

Enterprise Value

BEAM$2.52B

IRON$2.33B

Price

BEAM$25.70

IRON$62.06

P/E Ratio

BEAMN/A

IRONN/A

P/S Ratio

BEAM16.95x

IRON0.00x

EV/Sales

BEAM16.18x

IRON0.00x

EV/EBITDA

BEAM0.00x

IRON0.00x

P/B Ratio

BEAM2.37x

IRON3.84x

P/FCF Ratio

BEAMN/A

IRONN/A

EV/FCF

BEAM-6.77x

IRON-11.80x

PEG Ratio

BEAMN/A

IRONN/A

Forward P/E (NTM)

BEAMN/A

IRONN/A

Forward P/S (NTM)

BEAM38.86x

IRONN/A

Revenue (TTM)

BEAM$156M

IRON$0

Revenue Growth (YoY)

BEAM158.9%

IRONN/A

Forward Rev Growth

BEAM17.9%

IRON300.5%

Gross Margin (TTM)

BEAM0.0%

IRON0.0%

Operating Margin (TTM)

BEAM0.0%

IRON0.0%

EBITDA Margin (TTM)

BEAM-228.0%

IRON0.0%

Net Margin (TTM)

BEAM-54.7%

IRON0.0%

FCF Margin (TTM)

BEAM-238.9%

IRONN/A

Net Income (TTM)

BEAM$-85M

IRON$-246M

FCF (TTM)

BEAM$-373M

IRON$-198M

EPS (TTM)

BEAM-$0.82

IRON-$6.36

ROE (TTM)

BEAM-770.0%

IRON-3717.0%

ROA (TTM)

BEAM-604.0%

IRON-3365.0%

ROIC (TTM)

BEAM-737.0%

IRON-3522.0%

Cash

BEAM$220M

IRON$99M

Debt

BEAM$100M

IRON$59M

Net Cash/Debt

BEAM$120M

IRON$39M

Current Ratio (TTM)

BEAM14.57x

IRON24.14x

Quick Ratio (TTM)

BEAM14.25x

IRON23.64x

Debt/Equity (TTM)

BEAM0.09x

IRON0.09x

Debt/Assets (TTM)

BEAM0.0%

IRON0.0%

Interest Coverage (TTM)

BEAMN/A

IRONN/A

Net Debt/EBITDA (TTM)

BEAM0.00x

IRON0.00x

Beta

BEAM2.26

IRON0.95

52W Performance

BEAM-4.8%

IRON-11.7%

YTD Performance

BEAM-5.3%

IRON-21.5%

% from 52W High

BEAM-32.8%

IRON-37.6%

% from 52W Low

BEAM27.0%

IRON55.2%

Asset Turnover (TTM)

BEAM0.11x

IRON0.00x

FCF Yield (TTM)

BEAM-14.1%

IRON-8.3%

Earnings Yield (TTM)

BEAM-3.2%

IRON-10.4%

Dividend Yield (TTM)

BEAMN/A

IRONN/A

Rule of 40

BEAM-80.0

IRON0.0

EV/GP/RG

BEAMN/A

IRONN/A

Ticker research

View BEAM research View IRON research

Metric	BEAM Beam Therapeutics Inc	IRON Disc Medicine Inc
Market & Valuation
Market Cap	$2.64B	$2.37B
Enterprise Value	$2.52B	$2.33B
Price	$25.70	$62.06
P/E Ratio	N/A	N/A
P/S Ratio	16.95x	0.00x
EV/Sales	16.18x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.37x	3.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.77x	-11.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	38.86x	N/A
Revenue & Growth
Revenue (TTM)	$156M	$0
Revenue Growth (YoY)	158.9%	N/A
Forward Rev Growth	17.9%	300.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-228.0%	0.0%
Net Margin (TTM)	-54.7%	0.0%
FCF Margin (TTM)	-238.9%	N/A
Net Income (TTM)	$-85M	$-246M
FCF (TTM)	$-373M	$-198M
EPS (TTM)	-$0.82	-$6.36
ROE (TTM)	-770.0%	-3717.0%
ROA (TTM)	-604.0%	-3365.0%
ROIC (TTM)	-737.0%	-3522.0%
Financial Health
Cash	$220M	$99M
Debt	$100M	$59M
Net Cash/Debt	$120M	$39M
Current Ratio (TTM)	14.57x	24.14x
Quick Ratio (TTM)	14.25x	23.64x
Debt/Equity (TTM)	0.09x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	0.95
52W Performance	-4.8%	-11.7%
YTD Performance	-5.3%	-21.5%
% from 52W High	-32.8%	-37.6%
% from 52W Low	27.0%	55.2%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-14.1%	-8.3%
Earnings Yield (TTM)	-3.2%	-10.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-80.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BEAM research	View IRON research